surmount-1 tirzepatide non-diabetic obesity weight loss lowers body for adults with obesity, regardless of disease duration Effect of tirzepatide in SURMOUNT-1
Description
[DOI] [PubMed] [Google Scholar] 11
Warehouses Tirzepatide (GLP2-T), also designated LY3298176, is a synthetic dual-receptor agonist peptide supplied by Nextday Peptides for laboratory and analytical research applications
A 5mg target dose would deliver approximately 3.9mg
To put this in perspective, other vendors testing tirzepatide through the same independent lab achieved A ratings
Compounding pharmacies reconstitute lyophilized powder with varying amounts of bacteriostatic water for peptides , resulting in different concentrations
What is the typical dosing regimen for tirzepatide
